Orchestra BioMed Holdings Inc. (OBIO) — Cash Flow Quality Index
Latest as of December 2025:
-0.36x
Orchestra BioMed Holdings Inc. (OBIO) has a Cash Flow Quality Index of -0.36x as of December 2025. Operating cash flow of $-2.27 Million is below net income of $6.25 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore OBIO strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.36x
Operating CF / Net Income
Operating Cash Flow
$-2.27 Million
USD
Net Income
$6.25 Million
USD
Data as of
Dec 2025
Most recent filing
Annual Cash Flow Quality Index for Orchestra BioMed Holdings Inc. (None–None)
Year-by-year earnings quality comparison for Orchestra BioMed Holdings Inc.. For live market cap and the full company financial profile, see Orchestra BioMed Holdings Inc. market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.